Differential modulation of P-glycoprotein expression and activity by non-nucleoside HIV-1 reverse transcriptase inhibitors in cell culture.
- 1 January 2002
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 19 (7) , 1038-1045
- https://doi.org/10.1023/a:1016430825740
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Microsomal Metabolism of Delavirdine: Evidence for Mechanism-Based Inactivation of Human Cytochrome P450 3AThe Journal of Pharmacology and Experimental Therapeutics, 2025
- Cell cultures as tools in biopharmacyEuropean Journal of Pharmaceutical Sciences, 2000
- Induction of P-glycoprotein expression by HIV protease inhibitors in cell cultureAIDS, 2000
- Pharmacokinetics and Potential Interactions Amongst Antiretroviral Agents Used To Treat Patients with HIV InfectionClinical Pharmacokinetics, 1999
- Interrelationship Between Substrates and Inhibitors of Human CYP3A and P-GlycoproteinPharmaceutical Research, 1999
- Characterization of the Regional Intestinal Kinetics of Drug Efflux in Rat and Human Intestine and in Caco-2 CellsPharmaceutical Research, 1998
- Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen.1994
- Increased mdr-1/P-glycoprotein expression after treatment of human colon carcinoma cells with P-glycoprotein antagonists.1993
- Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cellsBiochemical and Biophysical Research Communications, 1991
- Multidrug-resistance phenotype in Chinese hamster ovary cells.1983